Hemostemix Inc. (HMTXF)

Hemostemix Statistics

Total Valuation

Hemostemix has a market cap or net worth of 11.46 million. The enterprise value is 13.03 million.

Market Cap	11.46M
Enterprise Value	13.03M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	195.25M
Shares Outstanding	n/a
Shares Change (YoY)	+54.08%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.87%
Owned by Institutions (%)	n/a
Float	154.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-4.61
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.54

Current Ratio	1.54
Quick Ratio	1.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.56

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-327.22%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-833.18%
Weighted Average Cost of Capital (WACC)	9.03%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.34% in the last 52 weeks. The beta is 0.59, so Hemostemix's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-68.34%
50-Day Moving Average	0.07
200-Day Moving Average	0.09
Relative Strength Index (RSI)	50.25
Average Volume (20 Days)	20,646

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.81M
Pretax Income	-2.44M
Net Income	-2.44M
EBITDA	-2.81M
EBIT	-2.81M
Earnings Per Share (EPS)	-0.02

Balance Sheet

The company has 934,952 in cash and 2.47 million in debt, with a net cash position of -1.54 million.

Cash & Cash Equivalents	934,952
Total Debt	2.47M
Net Cash	-1.54M
Net Cash Per Share	n/a
Equity (Book Value)	-2.48M
Book Value Per Share	-0.01
Working Capital	337,681

Cash Flow

Operating Cash Flow	-3.72M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Hemostemix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.08%
Shareholder Yield	-54.08%
Earnings Yield	-21.30%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 30, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Dec 30, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	2